Hugel Participates in AMWC ASIA in Taipei, Targeting Taiwan Market

Hugel Co., Ltd., a global total medical aesthetics company, is strategically targeting Taiwan, which is considered one of the top five countries in the Asian botulinum toxin market.

Hugel announced that it participated in 'AMWC ASIA & TDAC 2026,' held at the Taipei International Convention Center in Taiwan from May 2 to May 3.

Employees of Hugel's Taiwan branch are taking a commemorative photo at the 'AMWC ASIA & TDAC 2026' event in Taiwan. Hugel

'AMWC ASIA & TDAC (Aesthetic & Anti-aging Medicine World Congress & Taiwan Dermatology Aesthetic Conference)' is an international academic conference where medical professionals and industry representatives from around the world, primarily Asia, gather to share the latest procedure trends and clinical experiences. This year, the event attracted more than 2,000 visitors.

At this conference, Hugel drew significant interest from local medical professionals by showcasing its entire product portfolio, including the botulinum toxin 'Letybo,' the HA filler 'Revolax,' and cosmetics such as 'Byryzn BR' and 'Wellage.'

In particular, Hugel highlighted the unique advantages of each product and the strengths of combination treatments, promoting its bundling strategy. At the same time, the company actively sought new business opportunities through meetings with visitors.

Hugel has reinforced its presence in the local market by establishing a direct distribution system centered on its Taiwanese subsidiary. After recording a market share of about 10% in its first year of launch in 2019, the company expanded its share to approximately 30% as of last year, firmly securing the No. 2 position in the market.

Jang Doohyun, CEO of Hugel, said, "Through our participation in this event, we have reaffirmed our network with local medical professionals in Taiwan as well as our brand competitiveness," adding, "Based on our bundling strategy with fillers and cosmetics, we will further strengthen the competitiveness of our product portfolio and strive to become the No. 1 player in Taiwan's market share."

This content was produced with the assistance of AI translation services.